NCT07216677

Brief Summary

This is a real world investigation of patient who have undergone treatments for chronic eye conditions such as glaucoma and AMD.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
18mo left

Started Oct 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Oct 2024Oct 2027

Study Start

First participant enrolled

October 10, 2024

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

October 10, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 14, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 25, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 25, 2027

Last Updated

October 15, 2025

Status Verified

October 1, 2025

Enrollment Period

3 years

First QC Date

October 10, 2025

Last Update Submit

October 13, 2025

Conditions

Keywords

Glaucoma AMD

Outcome Measures

Primary Outcomes (1)

  • Changes in Chronic Disease Interventional outcomes such as Intraocular pressure, best corrected vision and other parameters.

    Longitudinal change in interventional chronic disease outcomes

    up to 12 months

Study Arms (1)

Post-intervention Observational Group

Other: Chronic Disease Intervention CDI

Interventions

Intervention for the management of a chronic eye disease

Post-intervention Observational Group

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with a chronic eye disease

You may qualify if:

  • Clinical diagnosis of Glaucoma or AMD or Diabetic Retinopathy Recent history of a chronic disease intervention in the prior 6 months

You may not qualify if:

  • Patient who are pregnant lactating younger than 18 years of age unable to execute informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Interstat

White Plains, New York, 10602, United States

Location

MeSH Terms

Conditions

GlaucomaDiabetic Retinopathy

Condition Hierarchy (Ancestors)

Ocular HypertensionEye DiseasesRetinal DiseasesDiabetic AngiopathiesVascular DiseasesCardiovascular DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ophthalmologist

Study Record Dates

First Submitted

October 10, 2025

First Posted

October 14, 2025

Study Start

October 10, 2024

Primary Completion (Estimated)

October 25, 2027

Study Completion (Estimated)

October 25, 2027

Last Updated

October 15, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations